Dr. Barry Hardy is Chief Executive Officer of Edelweiss Connect GmbH, Switzerland, and President of the OpenTox Association, an international community advancing predictive toxicology and innovative approaches to chemical and material safety assessment.

He has extensive experience in computational toxicology, scientific informatics, knowledge management and the development of digital infrastructures supporting collaborative research and industrial innovation. He has played leading roles in European research initiatives, including OpenTox, ToxBank, eNanoMapper, OpenRiskNet, ACEnano, NanoCommons and EU-ToxRisk.

His work focuses on translating scientific advances into practical solutions for industrial product design and safety assessment, particularly through New Approach Methodologies (NAMs), artificial intelligence, FAIR data management, predictive modelling and Next-Generation Risk Assessment (NGRA).